Research Insight
Capravirine – Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is a Non-Nuclesoide Reverse Transcriptase Inhibitor (NNRTI) that was under development for the treatment of patients infected...
Research Insight
Recycled blood is better than donated blood for transfusions, Hopkins study finds
We recycle a lot of things — paper, plastic, metal, blood. Yes, blood. During some surgeries, operating room personnel try to capture as much blood...
Research Insight
Abraxane for the Treatment of Late-Stage Pancreatic Cancer, United States of America
Abraxane (albumin-bound paclitaxel for injectable suspension) is an intravenous injection indicated for the treatment of metastatic pancreatic cancer. The drug was originally developed by Abraxis...
Research Insight
Zonegran (Zonisamide) for the Treatment of Epilepsy, Switzerland
Zonegran (Zonisamide) is an anti-epileptic drug indicated for the treatment of partial seizures in adults with epilepsy with or without secondary generalisation. ...
Research Insight
Cetilistat – Investigational Drug for Obesity, Japan
Developed by Alizyme, a specialist biopharmaceutical company in collaboration with Takeda Pharmaceutical, cetilistat (ATL-962) is an experimental treatment for obesity. Cetilistat restricts pancreatic lipases and...
Research Insight
Drug to fight leukemia in sight, say Australian researchers
After discovering a potential molecular "target" for leukemia, Australian researchers say a drug to fight the disease is "in their sights," although it is still...
Research Insight
Pharma 2020
A recent study by PricewaterhouseCoopers (PwC) examined the future of pharma and revealed essential technological and IT strategies. Developments in manufacturing, research and development (R&D),...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.